A new study shows that inhaled glucocorticoids fluticasone Propionates (fluticasone propionate) to 1 to 3-year-old children with asthma patients with recurrent effect than Segansuanna (sodium cromoglycate), and do not affect children Growth. Respectively fluticasone and Segansuanna treatment of children 1 year, the growth of no discrimination of any kind.
The researchers said that the three children under the age of the short-term research results showed that they receive fluticasone or budesonide (budesonide) after treatment, reducing the growth of lower limbs, but these drugs on children's development of long-term impact of less visible.
Copenhagen University Hospital researchers, the 625 cases with mild to moderate asthma relapse of 1 to 3-year-old children to study, compared the use fluticasone Propionates inhalation and one-year period Segansuanna security And efficacy.
The results showed that two groups of children in one year after the growth of the same, and the two groups does not appear in almost any drug-related adverse reactions.
The researchers noted that the effect of fluticasone statistically superior to Segansuanna, not only the deterioration of the illness less, and better control symptoms and reduce the relief of drug use. The study provides a reliable safety data, allowing for the inhaled glucocorticoids of the children suffering from asthma to early treatment. (China Medical Network)
The researchers said that the three children under the age of the short-term research results showed that they receive fluticasone or budesonide (budesonide) after treatment, reducing the growth of lower limbs, but these drugs on children's development of long-term impact of less visible.
Copenhagen University Hospital researchers, the 625 cases with mild to moderate asthma relapse of 1 to 3-year-old children to study, compared the use fluticasone Propionates inhalation and one-year period Segansuanna security And efficacy.
The results showed that two groups of children in one year after the growth of the same, and the two groups does not appear in almost any drug-related adverse reactions.
The researchers noted that the effect of fluticasone statistically superior to Segansuanna, not only the deterioration of the illness less, and better control symptoms and reduce the relief of drug use. The study provides a reliable safety data, allowing for the inhaled glucocorticoids of the children suffering from asthma to early treatment. (China Medical Network)
Fluticasone long-term treatment of recurrent asthma does not affect children's growth由Medical Network整理，请点击Fluticasone long-term treatment of recurrent asthma does not affect children's growth搜索更多相关内容。